- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Onconic Therapeutics Inc (476060)
Track today's live Onconic Therapeutics (476060) share price, performance and key data on this page with our current KOSDAQ:476060 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Onconic Therapeutics share price on the KOSDAQ exchange. Use the dropdown to switch exchange for the 476060 share price, head to our technical summary section, which provides analysis on Onconic Therapeutics share price buy/sell indicators using real-time data (or discuss the Onconic Therapeutics (476060) stock price today with other investors in the Onconic Therapeutics KQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KQ:476060 share price (ISIN: KR7476060009) to enhance your trading decisions with our free investment tools and resources.
What Is the Onconic Therapeutics Inc Share Price Today?
The Onconic Therapeutics share price today is 15,330.
What Is the Stock Symbol for Onconic Therapeutics Inc
The stock symbol (or 'ticker') for Onconic Therapeutics Inc is "476060."
What Stock Exchange Does Onconic Therapeutics Inc Trade On?
Onconic Therapeutics Inc is listed and trades on the KOSDAQ stock exchange.
Is Onconic Therapeutics Inc a Good Stock to Buy?
Determining whether Onconic Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current KQ:476060 share price (ISIN: KR7476060009) to enhance your trading decisions with our free investment tools and resources.
What Is the Onconic Therapeutics Inc Share Price Today?
The Onconic Therapeutics share price today is 15,330.
What Is the Stock Symbol for Onconic Therapeutics Inc
The stock symbol (or 'ticker') for Onconic Therapeutics Inc is "476060."
What Stock Exchange Does Onconic Therapeutics Inc Trade On?
Onconic Therapeutics Inc is listed and trades on the KOSDAQ stock exchange.
Is Onconic Therapeutics Inc a Good Stock to Buy?
Determining whether Onconic Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
15,330
-650(-4.07%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15,150
15,670
52 wk Range
8,790
65,200
476060 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15,15015,670
52 wk Range
8,79065,200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
476060 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Earnings
Latest Release
12/08/2026
EPS / Forecast
82.20 / --
Revenue / Forecast
21.2B / --
Compare 476060 to Peers and Sector
Metrics to compare | 476060 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship476060PeersSector | |
|---|---|---|---|---|
P/E Ratio | 28.7x | −12.7x | −0.4x | |
PEG Ratio | 0.08 | −0.09 | 0.00 | |
Price/Book | 8.1x | 2.5x | 2.6x | |
Price / LTM Sales | 8.5x | 14.3x | 3.0x | |
Upside (Analyst Target) | - | −2.6% | 57.5% | |
Fair Value Upside | Unlock | 5.1% | 7.8% | Unlock |
Onconic Therapeutics Inc. engages in the research and development of anti-cancer therapy in South Korea. It develops Zastaprazan (OCN-101), a potassium-competitive acid blocker, which is in phase 3 for the treatment of gastric acid related disease; and OCN-201 (JPI-547), an anticancer drug; JP-1366, a treatment for peptic ulcer; and drugs for DDR and immuno-oncology fields. JP-1366, a poly ADP-ribose polymerase inhibitor, which is in phase 1 for the treatment of pancreatic cancer. The company was founded in 2020 and is based in Seoul, South Korea.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Onconic Therapeutics (KOSDAQ: 476060) Share Price Today?
The Onconic Therapeutics stock price today is 15,330 KRW.
What Stock Exchange Does Onconic Therapeutics (476060) Trade On?
Onconic Therapeutics is listed and trades on the KOSDAQ.
What Is the Ticker (Stock Symbol) for Onconic Therapeutics?
The stock symbol (also called a 'ticker') for Onconic Therapeutics is "476060."
What Is the Current Onconic Therapeutics Market Capitalisation?
As of today, Onconic Therapeutics (KOSDAQ: 476060) market cap is 725.62B KRW.
What Is Onconic Therapeutics's (476060) Earnings Per Share (TTM)?
The Onconic Therapeutics EPS is currently 529 (Trailing Twelve Months).
When Is the Next Onconic Therapeutics Earnings Date?
Onconic Therapeutics's next earnings report will be released on 17/11/2026.
Is 476060 a Buy or Sell From a Technical Analyst Perspective?
Based on today's Onconic Therapeutics moving averages and other technical indicators, the daily buy/sell signal for 476060 stock is Strong Buy.
How Many Times Has Onconic Therapeutics Stock Split?
Onconic Therapeutics has split 1 times. (See the 476060 stock split history page for full effective split date and price information.)
What is the current trading status of Onconic Therapeutics (KOSDAQ: 476060)?
As of 29/09/2026, Onconic Therapeutics (476060) is trading at a share price of 15,330 KRW, with a previous close of 15,980 KRW. The stock has fluctuated within a day range of 15,150 KRW to 15,670 KRW, while its 52-week range spans from 8,790 KRW to 65,200 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.